Oct 30, 2015 | Birth Defects, Drug Side Effects, Pharmaceutical Litigation
Off Label Usage of Anti Nausea Drug Zofran Linked to Birth Defects Since the drug Zofran was approved by the FDA in 1991 to treat nausea in cancer patients undergoing chemotherapy, it has been marketed and prescribed as an anti-nausea and anti-vomiting drug for...
Aug 11, 2015 | Defective Drugs, Drug Side Effects, Personal Injury, Pharmaceutical Litigation
Anti Nausea Drug Zofran Linked to Serious Birth Defects Zofran is used as an anti nausea drug, and was intended for providing relief to chemotherapy patients. The Food and Drug Administration (FDA) approved Zofran for treating the severe nausea and vomiting associated...
